Skip to content Visiting from the US? Discover Helixafe, our Cancer Driver Interception program →

Cancer driver interception

Explore

Healthy longevity

Explore

Stem cells & exosomes

Explore

Prenatal & neonatal genomics

Explore

NGTX

Food supplements

Explore

Cancer driver interception

Primary prevention program

Dr. Mucci in the national premiere presents HELIXAFE at the Maurizio Costanzo Show

How to get it

Request the HELIXAFE protocol

Ask the experts

Prevention Diagnosis Predisposition Protocol Oncogenetic Patent

Prevention - Monitoring of Genetic Stability

Diagnosis - Biomolecular Pathology

#lung

#breast

Cancer

Assay

Cancer

Sequencing

Dr. Mucci in the national premiere presents HELIXAFE at the Maurizio Costanzo Show

HELIXAFE is a primary prevention program aimed at assessing the risk of solid tumors, except those in the brain.

Scientific content reviewed by the Bioscience Institute Scientific Board. · Last updated 2020-06-22

The information on this page is for general education and does not replace a consultation with a physician.

This page in other languages: Italiano

Cancer driver interception

Periodic monitoring of the four biological drivers that precede cancer, through five laboratory protocols.

Periodic monitoring of the four biological drivers that precede cancer: genomic instability, microbiome dysbiosis, chronic inflammation and immune dysfunction. A patented method, published in Cell Death & Disease.

Request the HELIXAFE protocol Explore HELIXAFE

Helixafe · US

Primary prevention program

Prevention - Monitoring of Genetic Stability

Diagnosis - Biomolecular Pathology

#lung

#breast

Cancer

Cancer

Assay

Cancer

Cancer

Sequencing

Periodic monitoring of the four biological drivers that precede cancer, through five laboratory protocols.

Connect with us on social